ARCUTIS BIOTHERAPEUTICS

Arcutis Biotherapeutics is a privately held clinical-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. The company was founded in 2016 and is based in Westlake Village, California.

#People #Financial #Website #More

ARCUTIS BIOTHERAPEUTICS

Social Links:

Linkedin

Twitter

Industry:

Biopharma Biotechnology Health Diagnostics Pharmaceutical Therapeutics

Founded:

2016-01-06

Address:

Westlake Village, California, United States

Country:

United States

Website Url:

http://www.arcutis.com

Total Employee:

101+

Status:

Active

Contact:

805-418-5006

Email Addresses:

[email protected]

Total Funding:

583.5 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome

Current Advisors List

halley-gilbert_image

HALLEY GILBERT Board Member @ Arcutis Biotherapeutics
Board_member
2020-04-01

howard-welgus_image

Howard Welgus Board Member @ Arcutis Biotherapeutics
Board_member

Current Employees Featured

john-smither_image

John Smither
John Smither Chief Financial Officer @ Arcutis Biotherapeutics
Chief Financial Officer
2019-05-01

matthew-moore_image

Matthew Moore
Matthew Moore Chief Business Officer @ Arcutis Biotherapeutics
Chief Business Officer
2021-01-01

david-osborne_image

David Osborne
David Osborne Chief Technical Officer @ Arcutis Biotherapeutics
Chief Technical Officer

patricia-turney_image

Patricia Turney
Patricia Turney SVP, Operations @ Arcutis Biotherapeutics
SVP, Operations
2020-01-01

patrick-burnett_image

Patrick Burnett
Patrick Burnett Chief Medical Officer @ Arcutis Biotherapeutics
Chief Medical Officer

kenneth-lock_image

Kenneth Lock
Kenneth Lock Chief Commercial Officer @ Arcutis Biotherapeutics
Chief Commercial Officer

frank-watanabe_image

Frank Watanabe
Frank Watanabe President and CEO @ Arcutis Biotherapeutics
President and CEO

howard-welgus_image

Howard Welgus
Howard Welgus Chief Medical Officer @ Arcutis Biotherapeutics
Chief Medical Officer

Founder

bhaskar-chaudhuri_image

Bhaskar Chaudhuri

david-osborne_image

David Osborne

Stock Details

Company's stock symbol is NASDAQ:ARQT

Acquisitions List

Date	Company	Article	Price
2022-09-08	Ducentis BioTherapeutics	Ducentis BioTherapeutics acquired by Arcutis Biotherapeutics	400 M USD

Investors List

solar-capital-partners_image

SLR Capital Partners

SLR Capital Partners investment in Post-IPO Debt - Arcutis Biotherapeutics

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series C - Arcutis Biotherapeutics

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series C - Arcutis Biotherapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series C - Arcutis Biotherapeutics

blackrock_image

BlackRock

BlackRock investment in Series C - Arcutis Biotherapeutics

pivotal-bioventure-partners_image

Pivotal bioVenture Partners

Pivotal bioVenture Partners investment in Series C - Arcutis Biotherapeutics

goldman-sachs_image

Goldman Sachs

Goldman Sachs investment in Series C - Arcutis Biotherapeutics

omega-funds_image

Omega Funds

Omega Funds investment in Series C - Arcutis Biotherapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Arcutis Biotherapeutics

bain-capital_image

Bain Capital

Bain Capital investment in Series C - Arcutis Biotherapeutics

Official Site Inspections

http://www.arcutis.com Semrush global rank: 4.02 M Semrush visits lastest month: 3.07 K

Host Informations
Whois Informations

Loading ...

More informations about "Arcutis Biotherapeutics" on Search Engine